Dr Ian Ellul PhD[Paed.][Melit.] has been the managing editor of The Synapse Journal since 2005. He was also Director of Pharmacy Services at a private hospital group, the government's Clinical Trials Coordinator for trials conducted in Malta, as well as senior regulatory affairs officer.
by Ian Ellul - Last May, Health Secretary Jeremy Hunt announced that 450,000 women between the ages of 68 and 71 in the UK failed to receive invitations for a final routine breast cancer screening.
Ian Ellul - As discussed in the last editorial, modern gene editing is quite precise but it is not perfect.
I wish to start 2018 by discussing gene editing which, following last year’s remarkable advances, is rumoured to continue to make a star appearance on stage. Gene editing basically rewrites DNA, disabling target genes, correcting harmful mutations and changing the activity of specific genes.
Ian Ellul - Think Dementia…
Dr Ian Ellul - eLearning VS traditional face-to-face interaction